CJ-15336

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameCJ-15336

Drug Alias NameCJ-15336

ClassificationNatural product/ExtractSmall molecules

Mechanisms of ActionTumor necrosis factor α inhibitorsInterleukin-1 beta inhibitors

TargetsTumor necrosis factor αInterleukin-1 beta

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A